Lipoprotein (a) where do we stand? from the physiopathology to innovative terapy
G Iannuzzo, M Tripaldella, V Mallardo, M Morgillo… - Biomedicines, 2021 - mdpi.com
A number of epidemiologic studies have demonstrated a strong association between
increasing lipoprotein a [Lp (a)] and cardiovascular disease. This correlation was …
increasing lipoprotein a [Lp (a)] and cardiovascular disease. This correlation was …
Lipoprotein (a) and Hypertension
NC Ward, JM Nolde, J Chan, R Carnagarin… - Current Hypertension …, 2021 - Springer
Abstract Purpose of Review To provide an overview of the associations between elevated
blood pressure and lipoprotein (a) and possible causal links, as well as data on the …
blood pressure and lipoprotein (a) and possible causal links, as well as data on the …
The iterative lipid impact on inflammation in atherosclerosis
JM Kraaijenhof, GK Hovingh, ESG Stroes… - Current opinion in …, 2021 - journals.lww.com
The iterative lipid impact on inflammation in atherosclerosi... : Current Opinion in Lipidology The
iterative lipid impact on inflammation in atherosclerosis : Current Opinion in Lipidology Log in or …
iterative lipid impact on inflammation in atherosclerosis : Current Opinion in Lipidology Log in or …
Association between lipoprotein (A) and diabetic nephropathy in patients with type 2 diabetes mellitus: a meta-analysis
X Ren, Z Zhang, Z Yan - Frontiers in Endocrinology, 2021 - frontiersin.org
Background Lipoprotein (a)[Lp (a)] has been well recognized as a risk factor of
cardiovascular disease. However, the association between serum Lp (a) and diabetic …
cardiovascular disease. However, the association between serum Lp (a) and diabetic …
Lipoprotein (a): current evidence for a physiologic role and the effects of nutraceutical strategies
HO Santos, R Kones, U Rumana, CP Earnest… - Clinical Therapeutics, 2019 - Elsevier
Purpose Cardiovascular (CV) diseases account for most worldwide mortality, and a higher
level of lipoprotein (Lp)-(a) is recognized as a prevalent contributing risk factor. However …
level of lipoprotein (Lp)-(a) is recognized as a prevalent contributing risk factor. However …
Lipids and lipoproteins in health and disease: focus on targeting atherosclerosis
CK Lee, CW Liao, SW Meng, WK Wu, JY Chiang… - Biomedicines, 2021 - mdpi.com
Despite advances in pharmacotherapy, intervention devices and techniques, residual
cardiovascular risks still cause a large burden on public health. Whilst most guidelines …
cardiovascular risks still cause a large burden on public health. Whilst most guidelines …
Lipid metabolism genes in stroke pathogenesis: the atherosclerosis
Stroke is the second leading cause of death and a major cause of disability worldwide. Both
modifiable and non-modifiable risk factors can affect the occurrence of ischemic stroke at …
modifiable and non-modifiable risk factors can affect the occurrence of ischemic stroke at …
Combined exercise training performed by elderly women reduces redox indexes and proinflammatory cytokines related to atherogenesis
Cardiovascular benefits for the general population of combined aerobic‐resistance exercise
training are well‐known, but the impact of this exercise training modality on the plasma lipid …
training are well‐known, but the impact of this exercise training modality on the plasma lipid …
Gene expression profiling of markers of inflammation, angiogenesis, coagulation and fibrinolysis in patients with coronary artery disease with very high lipoprotein (a) …
K Hrovat, A Rehberger Likozar, J Zupan… - Journal of …, 2022 - mdpi.com
Besides lipids, inflammation, angiogenesis, coagulation and fibrinolysis play very important
roles in coronary artery disease (CAD). We measured gene expression of the inflammatory …
roles in coronary artery disease (CAD). We measured gene expression of the inflammatory …
Circulating levels of PCSK9, ANGPTL3 and Lp (a) in stage III breast cancers
Background/synopsis Cholesterol and lipids play an important role in sustaining tumor
growth and metastasis in a large variety of cancers. ANGPTL3 and PCSK9 modify circulating …
growth and metastasis in a large variety of cancers. ANGPTL3 and PCSK9 modify circulating …